Author:
Leclair Valérie,Lundberg Ingrid E.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference48 articles.
1. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis;Gordon;Cochrane Database Syst Rev,2012
2. Patients with non-Jo-1 antitRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients;Aggarwal;Ann Rheum Dis,2014
3. Mortality and causes of death in patients with sporadic inclusion body myositis: survey study based on the clinical experience of specialists in Australia, Europe and the USA;Price;J Neuromuscul Dis,2016
4. Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids;Ibrahim;Rheumatology (Oxford),2015
5. A prospective, randomized, open-label, assessor-blind, multicenter study of efficacy and safety of combined treatment of methotrexate plus glucocorticoids versus glucocorticoids alone in patients with polymyositis and dermatomyositis (PROMETHEUS TRIAL);Studynkova;Ann Rheum Dis,2014
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献